0.7548

3.24% -0.0253

Hyperfine Inc (HYPR)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Hyperfine Inc stock is traded at $0.7548, with a volume of 559.31K. It is down -3.24% in the last 24 hours and down -2.51% over the past month. Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.

Previous Close:

$0.7801

Open:

$0.79

24h Volume:

559.31K

Relative Volume:

0.29

Market Cap:

$80.05M

Revenue:

$15.33M

Net Income/Loss:

$-34.78M

P/E Ratio:

-1.8468

EPS:

-0.4087

Net Cash Flow:

$-28.66M

1W Performance:

-18.90%

1M Performance:

-2.51%

6M Performance:

-43.25%

1Y Performance:

-46.85%

1-Day Range:

$0.7406

$0.79

1-Week Range:

$0.7406

$0.93

52-Week Range:

$0.7406

$1.935

Hyperfine Inc Stock (HYPR) Company Profile

Name

Hyperfine Inc

Sector

Healthcare (1052)

Industry

Medical Devices (143)

Phone

866-796-6767

Address

351 NEW WHITFIELD STREET, GUILFORD

Employee

102

Twitter

Next Earnings Date

2026-11-09

Latest SEC Filings

HYPR's Discussions on Twitter

Compare HYPR vs ABT, MDT, SYK, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HYPR Hyperfine Inc	0.7548	80.05M	15.33M	-34.78M	-28.66M	-0.4087
ABT Abbott Laboratories	104.89	181.50B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	94.75	121.20B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	294.66	113.02B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	44.39	64.33B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.60	49.92B	6.30B	1.07B	1.09B	1.8406

Hyperfine Inc Stock (HYPR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-29-26	Initiated	BTIG Research	Buy
Aug-11-22	Downgrade	Wells Fargo	Overweight → Equal Weight
May-31-22	Initiated	Evercore ISI	Outperform
Apr-14-22	Initiated	Wells Fargo	Overweight

Hyperfine Inc Stock (HYPR) Latest News

Oct 08, 2026

Preliminary Q3 revenue rises 55% year over year at Hyperfine (HYPR), topping net cash burn for the first time. - Stock Titan

Oct 08, 2026

Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million - Business Wire

Oct 08, 2026

Sep 17, 2026

Hyperfine Receives Nasdaq Minimum Bid Price Deficiency Notice - TipRanks

Sep 17, 2026

Sep 09, 2026

Lioness Medtech Showcasing Hyperfine Swoop at Röntgenveckan 2026 - marketscreener.com

Sep 09, 2026

Sep 04, 2026

HYPR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Sep 04, 2026

Sep 02, 2026

Hyperfine (HYPR) Holds at $0.81, Pressing Against Support After Mild PullbackMarket Neutral Pair - siam.in

Sep 02, 2026

Aug 31, 2026

Hyperfine Forms Global Neurosurgery Advisory Council - Medical Product Outsourcing

Aug 31, 2026

Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference - Yahoo Finance

Aug 31, 2026

Aug 28, 2026

Outset Medical, Inc. (OM) Stock Price & News - Syfe

Aug 28, 2026

Aug 26, 2026

Hyperfine reports 3,000 scans completed in first office year By Investing.com - Investing.com Nigeria

Aug 26, 2026

Hyperfine reports 3,000 scans completed in first office year By Investing.com - Investing.com Canada

Aug 26, 2026

Hyperfine reports 3,000 scans completed in first office year - investing.com

Aug 26, 2026

Aug 24, 2026

Hyperfine (HYPR) Earnings Update: The Available Earnings Metric Delivers a Beat at the Close; Market Response: Shares Finish 4.21% Down for the Current SessionEnergy Earnings Report - vinanet.vn

Aug 24, 2026

Aug 23, 2026

HYPR | Hyperfine, Inc. Class A FinancialsRevenue Breakdown - Quiver Quantitative

Aug 23, 2026

Aug 20, 2026

BTIG reiterates Hyperfine stock rating on FDA software clearance By Investing.com - Investing.com Canada

Aug 20, 2026

BTIG reiterates Hyperfine stock rating on FDA software clearance - Investing.com

Aug 20, 2026

Hyperfine Wins FDA Clearance for Next Optive AI Software - Medical Product Outsourcing

Aug 20, 2026

Hyperfine receives FDA clearance for Swoop MRI software update - Investing.com

Aug 20, 2026

Hyperfine receives FDA clearance for Swoop MRI software update By Investing.com - Investing.com South Africa

Aug 20, 2026

Hyperfine receives FDA clearance for Swoop MRI software update By Investing.com - Investing.com Nigeria

Aug 20, 2026

Hyperfine receives FDA clearance for Swoop MRI software update By Investing.com - Investing.com Canada

Aug 20, 2026

Hyperfine receives FDA clearance for Swoop MRI software update By Investing.com - Investing.com India

Aug 20, 2026

Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings - Business Wire

Aug 20, 2026

Aug 18, 2026

Hyperfine, Inc. (NASDAQ:HYPR) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Aug 18, 2026

Aug 15, 2026